Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...

Still, you largely own biotech stocks for the promise of their research and development (R&D) pipeline and the company's ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

If so, understanding how the pharmaceutical market defines brand value and knowing how your brand fulfils this definition is vital. To help you stand out from the crowd, this article presents some ...

The pharmaceutical industry faces stringent regulatory requirements to ensure the safety, efficacy, and quality of drug products. Among these, Current Good Manufacturing Practice (CGMP) guidelines set ...

15 analysts have expressed a variety of opinions on Vertex Pharmaceuticals (NASDAQ:VRTX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

Investors with a lot of money to spend have taken a bearish stance on Regeneron Pharmaceuticals REGN. And retail traders should know. We noticed this today when the trades showed up on publicly ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

During the last three months, 7 analysts shared their evaluations of Ligand Pharmaceuticals LGND, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...

West Pharmaceutical Services WST is scheduled to release third-quarter 2024 results on Oct. 10, before the opening bell. In the last reported quarter, the company delivered an earnings miss of 14.12%.

7 analysts have expressed a variety of opinions on Rhythm Pharmaceuticals (NASDAQ:RYTM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table ...